Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-26 Sale |
2025-02-28 4:15 pm |
Ovid Therapeutics Inc. | OVID | ALEXANDER MARGARET A. President and COO |
5,279 | $0.56 | $2,956 | 73,406 (Direct) |
View |
| 2025-02-26 Sale |
2025-02-28 4:15 pm |
Ovid Therapeutics Inc. | OVID | Rona Jeffrey A CBFO |
3,902 | $0.56 | $2,185 | 67,973 (Direct) |
View |
| 2025-01-27 Purchase |
2025-01-29 09:18 am |
Ovid Therapeutics Inc. | OVID | ALEXANDER MARGARET A. President and COO |
6,810 | $0.73 | $4,971 | 34,935 (Direct) |
View |
| 2024-03-18 Purchase |
2024-03-20 5:22 pm |
Ovid Therapeutics Inc. | OVID | LEVIN JEREMY M CEO |
18,248 | $2.76 | $50,364 | 3,652,176 (Indirect Direct) |
View |
| 2022-09-12 Sale |
2022-09-14 4:58 pm |
Ovid Therapeutics Inc. | OVID | Tardio Jason Chief Operating Officer |
17,344 | $2.15 | $37,290 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-03 Option Award |
2025-03-04 4:44 pm |
N/A 2035-03-02 |
Ovid Therapeutics Inc. | OVID | PAPADOPOULOS STELIOS Director |
90,000 | $0 | 90,000 (Direct) |
View |
Ownership |
2025-03-04 4:42 pm |
N/A N/A |
Ovid Therapeutics Inc. | OVID | PAPADOPOULOS STELIOS Director |
0 | $0 | 200,000 (Direct) |
View |
| 2025-02-20 Option Award |
2025-02-24 7:55 pm |
N/A 2035-02-19 |
Ovid Therapeutics Inc. | OVID | LEVIN JEREMY M CEO |
1,650,000 | $0 | 1,650,000 (Direct) |
View |
| 2025-02-20 Option Award |
2025-02-24 7:55 pm |
N/A 2035-02-19 |
Ovid Therapeutics Inc. | OVID | Rona Jeffrey A CBFO |
306,250 | $0 | 334,375 (Direct) |
View |
| 2025-02-20 Option Award |
2025-02-24 7:55 pm |
N/A 2035-02-19 |
Ovid Therapeutics Inc. | OVID | ALEXANDER MARGARET A. President and COO |
306,250 | $0 | 341,185 (Direct) |
View |
| 2024-12-12 Option Award |
2024-12-16 4:15 pm |
N/A 2034-12-11 |
Ovid Therapeutics Inc. | OVID | Fitzgerald Kevin Joseph Director |
90,000 | $0 | 90,000 (Direct) |
View |
| 2024-12-12 Option Award |
2024-12-16 4:15 pm |
N/A 2034-12-11 |
Ovid Therapeutics Inc. | OVID | Friedman Bart Director |
90,000 | $0 | 90,000 (Direct) |
View |
| 2024-12-12 Option Award |
2024-12-16 4:15 pm |
N/A 2034-12-11 |
Ovid Therapeutics Inc. | OVID | Duncan Barbara Gayle Director |
90,000 | $0 | 90,000 (Direct) |
View |
| 2024-12-12 Option Award |
2024-12-16 4:15 pm |
N/A 2034-12-11 |
Ovid Therapeutics Inc. | OVID | Bernstein Karen Director |
90,000 | $0 | 90,000 (Direct) |
View |
| 2024-09-09 Option Award |
2024-09-11 5:38 pm |
N/A 2034-09-08 |
Ovid Therapeutics Inc. | OVID | ALEXANDER MARGARET A. President and COO |
140,000 | $0 | 140,000 (Direct) |
View |
Ownership |
2024-09-11 5:36 pm |
N/A N/A |
Ovid Therapeutics Inc. | OVID | ALEXANDER MARGARET A. President and COO |
0 | $0 | 868,896 (Direct) |
View |
| 2024-07-30 Option Award |
2024-08-01 5:00 pm |
N/A 2034-07-29 |
Ovid Therapeutics Inc. | OVID | Rona Jeffrey A CBFO |
315,000 | $0 | 315,000 (Direct) |
View |
| 2024-02-22 Option Award |
2024-02-26 6:05 pm |
N/A 2034-02-21 |
Ovid Therapeutics Inc. | OVID | Tardio Jason Chief Operating Officer |
196,875 | $0 | 196,875 (Direct) |
View |
| 2024-02-22 Option Award |
2024-02-26 6:03 pm |
N/A 2034-02-21 |
Ovid Therapeutics Inc. | OVID | Rona Jeffrey A CBFO |
196,875 | $0 | 28,125 (Direct) |
View |
| 2024-02-22 Option Award |
2024-02-26 6:01 pm |
N/A 2034-02-21 |
Ovid Therapeutics Inc. | OVID | Poole Robert Michael Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2024-02-22 Option Award |
2024-02-26 6:00 pm |
N/A 2034-02-21 |
Ovid Therapeutics Inc. | OVID | Perone Thomas Michael General Counsel, Secretary |
196,875 | $0 | 196,875 (Direct) |
View |
| 2024-02-22 Option Award |
2024-02-26 5:58 pm |
N/A 2034-02-21 |
Ovid Therapeutics Inc. | OVID | LEVIN JEREMY M CEO |
700,000 | $0 | 700,000 (Direct) |
View |
| 2024-02-22 Option Award |
2024-02-26 5:57 pm |
N/A 2034-02-21 |
Ovid Therapeutics Inc. | OVID | Friedman Bart Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2024-02-22 Option Award |
2024-02-26 5:56 pm |
N/A 2034-02-21 |
Ovid Therapeutics Inc. | OVID | Fitzgerald Kevin Joseph Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2024-02-22 Option Award |
2024-02-26 5:54 pm |
N/A 2034-02-21 |
Ovid Therapeutics Inc. | OVID | Duncan Barbara Gayle Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2024-02-22 Option Award |
2024-02-26 5:53 pm |
N/A 2034-02-21 |
Ovid Therapeutics Inc. | OVID | Bernstein Karen Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-12-04 Gift |
2023-12-06 5:05 pm |
N/A N/A |
Ovid Therapeutics Inc. | OVID | LEVIN JEREMY M CEO |
573,275 | $0 | 3,633,928 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 5:27 pm |
N/A 2033-02-22 |
Ovid Therapeutics Inc. | OVID | Tardio Jason Chief Operating Officer |
175,000 | $0 | 175,000 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 5:24 pm |
N/A 2033-02-22 |
Ovid Therapeutics Inc. | OVID | Rona Jeffrey A CBFO |
175,000 | $0 | 175,000 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 5:01 pm |
N/A 2033-02-22 |
Ovid Therapeutics Inc. | OVID | Poole Robert Michael Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 5:00 pm |
N/A 2033-02-22 |
Ovid Therapeutics Inc. | OVID | Perone Thomas Michael General Counsel, Secretary |
175,000 | $0 | 175,000 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 4:58 pm |
N/A 2033-02-22 |
Ovid Therapeutics Inc. | OVID | LEVIN JEREMY M CEO 10% Owner |
600,000 | $0 | 600,000 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 4:55 pm |
N/A 2033-02-22 |
Ovid Therapeutics Inc. | OVID | Friedman Bart Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 4:51 pm |
N/A 2033-02-22 |
Ovid Therapeutics Inc. | OVID | Fitzgerald Kevin Joseph Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 4:47 pm |
N/A 2033-02-22 |
Ovid Therapeutics Inc. | OVID | Duncan Barbara Gayle Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 4:44 pm |
N/A 2033-02-22 |
Ovid Therapeutics Inc. | OVID | Bernstein Karen Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-07-01 Other |
2022-07-06 06:28 am |
N/A N/A |
Ovid Therapeutics Inc. | OVID | TAKEDA PHARMACEUTICAL CO LTD Takeda Pharmaceuticals U.S.A. Inc. 10% Owner |
5,752,500 | $0 | 19,033,246 (Indirect) |
View |
| 2022-04-08 Option Award |
2022-04-12 5:53 pm |
N/A 2032-04-07 |
Ovid Therapeutics Inc. | OVID | Friedman Bart Director |
69,424 | $0 | 69,424 (Direct) |
View |
| 2022-04-08 Option Award |
2022-04-12 5:40 pm |
N/A 2023-04-07 |
Ovid Therapeutics Inc. | OVID | Tardio Jason Chief Operating Officer |
97,498 | $0 | 97,498 (Direct) |
View |
| 2022-04-08 Option Award |
2022-04-12 5:36 pm |
N/A 2032-04-07 |
Ovid Therapeutics Inc. | OVID | LEVIN JEREMY M CEO 10% Owner |
423,244 | $0 | 423,244 (Direct) |
View |